SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	77.94	61.21	62.4	108.25	24	14.55
Cash & Short-Term Investments	77.94	61.21	62.4	108.25	24	14.55
Cash Growth	102.50%	-1.90%	-42.36%	351.08%	64.95%	315.06%
Other Receivables	21.01	14.43	12.41	14.7	10.67	6.46
Receivables	21.01	14.43	12.41	14.7	10.67	6.46
Prepaid Expenses	3.17	18.37	0.26	17.29	0.25	0.32
Other Current Assets	0	-0	-0	-0	0	-
Total Current Assets	102.11	94	75.06	140.23	34.92	21.33
Property, Plant & Equipment	1.4	1.94	0.66	2.1	3.18	-
Long-Term Investments	-	0.05	0.14	0.27	0.27	0.26
Long-Term Deferred Charges	149.93	154.59	152.16	-	-	-
Other Long-Term Assets	0.14	19.94	0	-	-	-
Total Assets	253.58	270.52	228.02	142.6	38.37	21.59
Accounts Payable	9.66	17.35	9.67	4.72	4.25	2.78
Accrued Expenses	20.57	10.09	9.82	4.91	7.89	2.76
Current Portion of Leases	0.62	0.6	0.58	1	0.98	-
Other Current Liabilities	0.31	0.42	4.88	4.38	2.27	0.19
Total Current Liabilities	31.15	28.46	24.94	15.01	15.39	5.73
Long-Term Leases	0.77	1.29	0.06	1.06	2.11	-
Long-Term Deferred Tax Liabilities	17.75	18.3	18.02	-	-	-
Other Long-Term Liabilities	9.08	8.3	8.82	-	-	-
Total Liabilities	58.76	56.35	51.83	16.08	17.5	5.73
Common Stock	6.67	5.81	4.45	3.71	3.25	3.05
Additional Paid-In Capital	835.1	762.8	646.57	394.84	193.6	119.4
Retained Earnings	-660.9	-573	-490.6	-274.79	-175.59	-106.28
Comprehensive Income & Other	13.96	18.56	15.77	2.77	-0.4	-0.3
Shareholders' Equity	194.83	214.17	176.19	126.52	20.87	15.87
Total Liabilities & Equity	253.58	270.52	228.02	142.6	38.37	21.59
Total Debt	1.39	1.88	0.64	2.06	3.09	-
Net Cash (Debt)	76.55	59.33	61.76	106.18	20.91	14.55
Net Cash Growth	106.56%	-3.94%	-41.84%	407.85%	43.72%	315.06%
Net Cash Per Share	1.59	1.50	1.90	3.85	0.81	0.68
Filing Date Shares Outstanding	53.33	46.49	35.57	31.82	26.01	24.41
Total Common Shares Outstanding	53.33	46.49	35.57	29.65	26.01	24.41
Working Capital	70.96	65.54	50.12	125.22	19.53	15.6
Book Value Per Share	3.65	4.61	4.95	4.27	0.80	0.65
Tangible Book Value	194.83	214.17	176.19	126.52	20.87	15.87
Tangible Book Value Per Share	3.65	4.61	4.95	4.27	0.80	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.